Boron neutron capture therapy (BNCT) in Finland: Technological and physical prospects after 20 years of experiences

Physica Medica

Volumn 29, Issue 3, 2013, Pages 233-248

  Savolainen, Sauli ^a,b   Kortesniemi, Mika ^a,b   Timonen, Marjut ^b   Reijonen, Vappu ^b   Kuusela, Linda ^a,b   Uusi Simola, Jouni ^b   Salli, Eero ^b   Koivunoro, Hanna ^a,b,c   Seppälä, Tiina ^b   Lönnroth, Nadja ^b   Välimäki, Petteri ^a,c   Hyvönen, Heini ^c   Kotiluoto, Petri ^d   Serén, Tom ^d   Kuronen, Antti ^a   Heikkinen, Sami ^a   Kosunen, Antti ^e   Auterinen, Iiro ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Boneca Corporation   (Finland)

^d VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^e STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

Beam dosimetry; Boron imaging and determination; Diffusion imaging; Dose calculation; Image registration; Neutron dosimetry; Neutron sources; Treatment planning

Indexed keywords

ATOMIC EMISSION SPECTROMETRY; COLLIMATOR; DOSIMETRY; EXPERIENCE; FINLAND; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MEDICAL RESEARCH; NEUTRON CAPTURE THERAPY; NEUTRON DOSIMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; RADIATION BEAM; RADIATION DOSE DISTRIBUTION; REVIEW; THERMOLUMINESCENCE DOSIMETRY; TREATMENT PLANNING; TREATMENT RESPONSE;

BORON NEUTRON CAPTURE THERAPY; FINLAND; FORECASTING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84876744396     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2012.04.008     Document Type: Review

References (173)

1. Joensuu H., Kankaanranta L., Seppälä T., Auterinen I., Kallio M., Kulvik M., et al. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol 2003, 62:123-134.
2. Kankaanranta L., Seppälä T., Koivunoro H., Saarilahti K., Atula T., Collan J., et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys 2011, 99:97-100.
3. Kankaanranta L., Seppälä T., Koivunoro H., Välimäki P., Beule A., Collan J., et al. l-Boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a phase I study. Int J Radiat Oncol Biol Phys 2011, 80:369-376.
4. Kouri M., Kankaanranta L., Seppälä T., Tervo L., Rasilainen M., Minn H., et al. Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother Oncol 2004, 72:83-85.
5. Barth R.F., Soloway A.H., Fairchild R.G., Brugger R.M. Boron neutron capture therapy for cancer. Realities and prospects. Cancer 1992, 70:2995-3007.
6. Barth R.F., Yang W., Rotaru J.H., Moeschberger M.L., Boesel C.P., Soloway A.H., et al. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys 2000, 47:209-218.
7. Barth R.F., Soloway A.H., Brugger R.M. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest 1996, 14:534-550.
8. Kankaanranta L., Seppälä T., Koivunoro H., Saarilahti K., Atula T., Collan J., et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007, 69:475-482.
9. Auterinen I., Hiismäki P., Kotiluoto P., Rosenberg R.J., Salmenhaara S., Seppälä T., et al. Metamorphosis of a 35 years old TRIGA reactor into a modern BNCT facility. Proceedings of frontiers in neutron capture therapy, La Jolla, United States 2001, 267-275.
10. Kankaanranta L., Saarilahti K., Makitie A., Valimaki P., Tenhunen M., Joensuu H. Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvement. Radiother Oncol 2011, 99:98-99.
11. Kortesniemi M. Solutions for clinical implementation of boron neutron capture therapy in Finland. PhD thesis. University of Helsinki, Helsinki; 2002.
12. Seppälä T. FiR 1 epithermal neutron beam model and dose calculation for treatment planning in neutron capture therapy. PhD thesis. University of Helsinki, Helsinki; 2002.
13. Koivunoro H., Seppälä T., Uusi-Simola J., Merimaa K., Kotiluoto P., Serén T., et al. Validation of dose planning calculations for boron neutron capture therapy using cylindrical and anthropomorphic phantoms. Phys Med Biol 2010, 55:3515-3533.
14. Salli E., Seppälä T., Koivunoro H., Kankaanranta L., Asikainen S., Savolainen S. Co-registration of the BNCT treatment planning images for clinical practice. Proceedings of international congress on neutron capture therapy, Kagawa, Japan 2006, 64-66.
15. International Commission on Radiation Units and Measurement (ICRU) Determination of absorbed dose in a patient irradiated by beams of X or gamma rays in radiotherapy procedures 1976, ICRU Publications, Report 24.
16. Recommendations for the dosimetry of boron neutron capture therapy (BNCT) 2003, The Nuclear Research and consultancy Group NRG, Report 21425/03.55339/C. H. Järvinen, W.P. Voorbraak (Eds.).
17. Välimäki J.P., Lampinen J.S., Kuronen A.A., Ilvonen S.A., Stepanek J., Savolainen S.E. Comparison of different cell-cluster models for cell-level dosimetry. Acta Oncol 2001, 40:92-97.
18. Barth R.F., Coderre J.A., Vicente M.G., Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 2005, 11:3987-4002.
19. Barth R.F. Boron neutron capture therapy at the crossroads: challenges and opportunities. Appl Radiat Isot 2009, 67:S3-S6.
20. International Atomic Energy Agency (IAEA) Current status of neutron capture therapy 2001, IAEA, Report IAEA-TECDOC-1223.
21. Feakes D. Chemistry and pharmacology of agents for BNCT. Frontiers in neutron capture therapy 2001, 23-34. Kluwer Academic/Plenum Publishing Corporation. M.F. Hawthorne, K. Shelly, R.J. Wiersema (Eds.).
22. Wu G., Barth R.F., Yang W., Lee R.J., Tjarks W., Backer M.V., et al. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med Chem 2006, 6:167-184.
23. Nigg D.W. Computational dosimetry and treatment planning considerations for neutron capture therapy. J Neurooncol 2003, 62:75-86.
24. Marek M., Viererbl L. Spatial characterization of BNCT beams. Appl Radiat Isot 2004, 61:1051-1055.
25. Binns P.J., Riley K.J., Harling O.K. Epithermal neutron beams for clinical studies of boron neutron capture therapy: a dosimetric comparison of seven beams. Radiat Res 2005, 164:212-220.
26. Seppälä T., Collan J., Auterinen I., Serén T., Salli E., Kotiluoto P., et al. A dosimetric study on the use of bolus materials for treatment of superficial tumors with BNCT. Appl Radiat Isot 2004, 61:787-791.
27. Tattam D.A., Allen D.A., Beynon T.D., Constantine G., Green S., Scott M.C., et al. In-phantom neutron fluence measurements in the orthogonal Birmingham boron neutron capture therapy beam. Med Phys 1998, 25:1964-1966.
28. Blue T.E., Yanch J.C. Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors. J Neurooncol 2003, 62:19-31.
29. Barth R.F., Joensuu H. Boron neutron capture therapy for the treatment of glioblastomas and extracranial tumours: as effective, more effective or less effective than photon irradiation?. Radiother Oncol 2007, 82:119-122.
30. Yanch J.C., Zhou X.L., Shefer R.E., Klinkowstein R.E. Accelerator-based epithermal neutron beam design for neutron capture therapy. Med Phys 1992, 19:709-721.
31. Barth R.F., Soloway A.H., Alam F., Clendenon N.R., Blue T.E., Mafune N., et al. Pre-clinical studies on boron neutron capture therapy. Basic Life Sci 1989, 50:95-105.
32. Wang C.K., Blue T.E., Blue J.W. An experimental study of the moderator assembly for a low-energy proton accelerator neutron irradiation facility for BNCT. Basic Life Sci 1990, 54:271-280.
33. Culbertson C.N., Green S., Mason A.J., Picton D., Baugh G., Hugtenburg R.P., et al. In-phantom characterisation studies at the Birmingham accelerator-generated epithermal neutron source (BAGINS) BNCT facility. Appl Radiat Isot 2004, 61:733-738.
34. Kreiner A.J., Thatar Vento V., Levinas P., Bergueiro J., Di Paolo H., Burlon A.A., et al. Development of a tandem-electrostatic-quadrupole accelerator facility for BNCT. Appl Radiat Isot 2009, 67:S266-S269.
35. Tanaka H., Sakurai Y., Suzuki M., Masunaga S., Kinashi Y., Kashino G., et al. Characteristics comparison between a cyclotron-based neutron source and KUR-HWNIF for boron neutron capture therapy. Nucl Inst Meth Phys Res B 2009, 267:1970-1977.
36. Tsukamoto T., Tanaka H., Yoshinaga H., Mitsumoto T., Maruhashi A., Ono K., et al. A phantom experiment for the evaluation of whole body exposure during BNCT using cyclotron-based epithermal neutron source (C-BENS). Appl Radiat Isot 2011, 69:1830-1833.
37. Esposito J., Colautti P., Fabritsiev S., Gervash A., Giniyatulin R., Lomasov V.N., et al. Be target development for the accelerator-based SPES-BNCT facility at INFN Legnaro. Appl Radiat Isot 2009, 67:S270-S273.
38. Ceballos C., Esposito J. The BSA modeling for the accelerator-based BNCT facility at INFN LNL for treating shallow skin melanoma. Appl Radiat Isot 2009, 67:S274-S277.
39. Ceballos C., Esposito J., Agosteo S., Colautti P., Conte V., Moro D., et al. Towards the final BSA modeling for the accelerator-driven BNCT facility at INFN LNL. Appl Radiat Isot 2011, 69:1660-1663.
40. Verbeke J.M., Vujic J.L., Leung K.N. Neutron beam optimization for boron neutron capture therapy using the D-D and D-T high-energy neutron sources. Nucl Technol 2000, 129:257-278.
41. Koivunoro H., Bleuel D.L., Nastasi U., Lou T.P., Reijonen J., Leung K.N. BNCT dose distribution in liver with epithermal D-D and D-T fusion-based neutron beams. Appl Radiat Isot 2004, 61:853-859.
42. Reijonen J., Leung K.N., Firestone R.B., English J.A., Perry D.L., Smith A., et al. First PGAA and NAA experimental results from a compact high intensity D-D neutron generator. Nucl Inst Meth Phys Res A 2004, 522:598-602.
43. Durisi E., Zanini A., Manfredotti C., Palamara F., Sarotto M., Visca L., et al. Design of an epithermal column for BNCT based D-D fusion neutron facility. Nucl Inst Meth Phys Res A 2007, 574:363-369.
44. Wambersie A., Van Dam J., Hanks G., Mijnheer B.J., Battermann J.J. What accuracy is needed in dosimetry? 1991, IAEA, Report IAEA-TECDOC-734. pp. 11-35.
45. IAEA Technical Report Series Absorbed dose determination in external beam radiotherapy, an international code of practise for dosimetry based on absorbed dose to water 2000, IAEA, Report 398.
46. Broerse J.J., Mijnheer B.J., Williams J.R. European protocol for neutron dosimetry for external beam therapy. European clinical neutron dosimetry group (ECNEU). Br J Radiol 1981, 54:882-898.
47. International Commission of Radiation Measurements and Units (ICRU) Clinical neutron dosimetry part I: determination of absorbed dose in a patient treated by external beams of fast neutrons 1989, ICRU Publications, Report 45.
48. American Association of Physicists in Medicine, Task Group 51 Protocol for clinical reference dosimetry of high-energy photon and electron beams. Med Phys 1999, 26:1847-1870.
49. Stecher-Rasmussen F., Auterinen I., Beddoe A., Goncalves I., Järvinen H., Kosunen A., et al. A code of practice for the dosimetry of BNCT in Europe. Proceedings of 7th international symposium on neutron capture therapy 1997, Elsevier Science B.V., Zürich.
50. Kosunen A., Kortesniemi M., Ylä-Mella H., Seppälä T., Lampinen J., Serén T., et al. Twin ionisation chambers for dose determinations in phantom in an epithermal neutron beam. Radiat Prot Dosim 1999, 81:187-194.
51. Rogus R.D., Harling O.K., Yanch J.C. Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor. Med Phys 1994, 21:1611-1625.
52. Raaijmakers C.P., Konijnenberg M.W., Verhagen H.W., Mijnheer B.J. Determination of dose components in phantoms irradiated with an epithermal neutron beam for boron neutron capture therapy. Med Phys 1995, 22:321-329.
53. Munck af Rosenschold P.M., Giusti V., Ceberg C.P., Capala J., Skold K., Persson B.R. Reference dosimetry at the neutron capture therapy facility at Studsvik. Med Phys 2003, 30:1569-1579.
54. Riley K.J., Binns P.J., Harling O.K. Performance characteristics of the MIT fission converter based epithermal neutron beam. Phys Med Biol 2003, 48:943-958.
55. International Commission on Radiation Units and Measurement (ICRU) Neutron dosimetry for biology and medicine 1977, ICRU Publications, Report 26.
56. Kutcher G.J., Coia L., Gillin M., Hanson W.F., Leibel S., Morton R.J., et al. Comprehensive QA for radiation oncology: report of AAPM radiation therapy committee task group 40. Med Phys 1994, 21:581-618.
57. Thwaites D., Scalliet P., Leer J.W., Overgaard J. Quality assurance in radiotherapy. European society for therapeutic radiology and oncology advisory report to the commission of the european union for the 'Europe against cancer programme'. Radiother Oncol 1995, 35:61-73.
58. Sauerwein W., Hideghety K., de Vries M., Watkins P., Vroegindeweij C., Grabe S., et al. The necessity and possibilities for standardization in medical application of BNCT 1998, Abstracts of eighth international symposium on neutron capture therapy for cancer.
59. Rassow J., Stecher-Rasmussen F., Appelman K., Garbe S., Morrissey J., Moss R., et al. Quality assurance for clinical dosimetry of the European trial on BNCT in Petten. Proceedings of eighth international symposium on neutron capture therapy for cancer, La Jolla, United States 1998.
60. Uusi-Simola J. Finnish dosimetric practice for epithermal neutron beam dosimetry in boron neutron capture therapy. PhD thesis. University of Helsinki, Helsinki; 2009.
61. Raaijmakers C.P., Watkins P.R., Nottelman E.L., Verhagen H.W., Jansen J.T., Zoetelief J., et al. The neutron sensitivity of dosimeters applied to boron neutron capture therapy. Med Phys 1996, 23:1581-1589.
62. Kaita K., Serén T., Auterinen I. First characterisation of the Finnish epithermal beam using activation detectors. Advances in neutron capture therapy 1997, 353-356. Elsevier Science B.V. B. Larsson, J. Crawford, R. Weinreich (Eds.).
63. Chadwick M.B., Barschall H.H., Caswell R.S., DeLuca P.M., Hale G.M., Jones D.T., et al. A consistent set of neutron kerma coefficients from thermal to 150 MeV for biologically important materials. Med Phys 1999, 26:974-991.
64. Kota C., Maughan R.L. A dosimetry system for boron neutron capture therapy based on the dual counter microdosimetric technique. Bull Cancer Radiother 1996, 83:173.
65. Bradley P.D., Rosenfeld A.B., Allen B.J., Kobayashi T., Sakurai Y., Kota C., et al. Application of silicon diode arrays for microdosimetry for BNCT and FNT. Proceedings of frontiers in neutron capture therapy, La Jolla, United States 2001, 615-621. Kluwer Academic/Plenum Publishing Corporation.
66. Uusi-Simola J., Serén T., Seppälä T., Kosunen A., Auterinen I., Savolainen S. Dosimetric comparison at FiR 1 using microdosimetry, ionisation chambers and computer simulation. Appl Radiat Isot 2004, 61:845-848.
67. Agosteo S., Colautti P., Fanton I., Fazzi A., Introini M.V., Moro D., et al. Study of a solid state microdosemeter based on a monolithic silicon telescope: irradiations with low-energy neutrons and direct comparison with a cylindrical TEPC. Radiat Prot Dosim 2011, 143:432-435.
68. Burmeister J., Kota C., Maughan R.L. Dosimetry of the boron neutron capture reaction for BNCT and BNCEFNT. Strahlenther Onkol 1999, 175:115-118.
69. Burmeister J., Kota C., Maughan R., Riley K., Harling O., Wielopolski L., et al. Microdosimetry studies at the BMRR and the MITR-II using miniature tissue-equivalent proportional counters. Frontiers in neutron capture therapy 2001, 581-586. Kluwer Academic/Plenum Publishing Corporation. M.F. Hawthorne, K. Shelly, R.J. Wiersema (Eds.).
70. Burmeister J., Kota C., Maughan R.L., Waker A.J., Riley K., Wielopolski L. Application of TEPC microdosimetry to boron neutron capture therapy. Radiat Prot Dosim 2002, 99:351-352.
71. Moro D., Colautti P., Lollo M., Esposito J., Conte V., De Nardo L., et al. BNCT dosimetry performed with a mini twin tissue-equivalent proportional counters (TEPC). Appl Radiat Isot 2009, 67:171-174.
72. Rosenfeld A.B. Semiconductor dosimetry in BNCT. Frontiers in neutron capture therapy 2001, 557-563. Kluwer Academic/Plenum Publishing Corporation. M.F. Hawthorne, K. Shelly, R.J. Wiersema (Eds.).
73. Pospisil S., Sopko B., Havránková E., Janout Z., Konicek J., Mácha I., et al. Si diode as a small detector of slow neutrons. Radiat Prot Dosim 1993, 46:118.
74. Kaplan G.I., Rosenfeld A.B., Allen B.J., Coderre J.A., Kobayashi T., Maughan R.L., et al. Semiconductor detectors for inphantom thermal neutron flux and boron dose measurements in BNCT and fast neutron therapy. Frontiers in neutron capture therapy 2001, 1175-1180. Kluwer Academic/Plenum Publishing Corporation. M.F. Hawthorne, K. Shelly, R.J. Wiersema (Eds.).
75. Perks C.A., Mill A.J., Constantine G., Harrison K.G., Gibson J.A. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research. Br J Radiol 1988, 61:1115-1126.
76. Aschan C., Toivonen M., Savolainen S., Seppälä T., Auterinen I. Epithermal neutron beam dosimetry with thermoluminescence dosemeters for boron neutron capture therapy. Radiat Prot Dosim 1999, 81:47-56.
77. Aschan C. Applicability of thermoluminescent dosimeters in X-Ray organ dose determination and in the dosimetry of systemic and boron neutron capture radiotherapy. PhD thesis. University of Helsinki, Helsinki; 1999.
78. Liu H.M., Hsu P.C., Liaw T.F. Gamma dose measurement in a water phantom irradiated with the BNCT facility at THOR. Radiat Prot Dosim 2001, 95:353-358.
79. Gambarini G., Klamert V., Agosteo S., Birattari C., Gay S., Rosi G., et al. Study of a method based on TLD detectors for in-phantom dosimetry in BNCT. Radiat Prot Dosim 2004, 110:631-636.
80. Burgkhardt B., Bilski P., Budzanowski M., Bottger R., Eberhardt K., Hampel G., et al. Application of different TL detectors for the photon dosimetry in mixed radiation fields used for BNCT. Radiat Prot Dosim 2006, 120:83-86.
81. Gambarini G., Agosteo S., Marchesi P., Nava E., Palazzi P., Pecci A., et al. Discrimination of various contributions to the absorbed dose in BNCT: fricke-gel imaging and intercomparison with other experimental results. Appl Radiat Isot 2000, 53:765-772.
82. Schmitz T., Blaickner M., Schutz C., Wiehl N., Kratz J.V., Bassler N., et al. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz. Acta Oncol 2010, 49:1165-1169.
83. Karila J., Seppälä T., Serén T., Kotiluoto P., Auterinen I., Aschan C., et al. The TL analysis methods used to determine absorbed gamma doses in vivo for the BNCT patients treated at FiR 1. Appl Radiat Isot 2004, 61:793-797.
84. Farajollahi A.R., Bonnett D.E., Tattam D., Green S. The potential use of polymer gel dosimetry in boron neutron capture therapy. Phys Med Biol 2000, 45:N9-N14.
85. Uusi-Simola J., Savolainen S., Kangasmäki A., Heikkinen S., Perkiö J., Abo Ramadan U., et al. Study of the relative dose-response of BANG-3 polymer gel dosimeters in epithermal neutron irradiation. Phys Med Biol 2003, 48:2895-2906.
86. Uusi-Simola J., Heikkinen S., Kotiluoto P., Serén T., Seppälä T., Auterinen I., et al. MAGIC polymer gel for dosimetric verification in boron neutron capture therapy. J Appl Clin Med Phys 2007, 8:114-123.
87. Davis M.H., Khotanzad A., Flamig D.P., Harms S.E. A physics-based coordinate transformation for 3-D image matching. IEEE Trans Med Imaging 1997, 16:317-328.
88. Collignon A., Maes F., Delaere D., Vandermeulen D., Suetens P., Marchal G. Automated multi-modality image registration based on information theory. Information processing in medical imaging 1995, 263-274. Kluwer Academic Publishers. Y. Bizais, C. Barillot, R. Di Paola (Eds.).
89. Wells W.M., Viola P., Atsumi H., Nakajima S., Kikinis R. Multi-modal volume registration by maximization of mutual information. Med Image Anal 1996, 1:35-51.
90. Mattes D., Haynor D.R., Vesselle H., Lewellyn T.K., Eubank W. Nonrigid multimodality image registration. Medical imaging 2001: image processing 2001, 1609-1620. M. Sonka, K.M. Hanson (Eds.).
91. Press W.H., Teukolsky S.A., Vetterling W.T., Flannery B.P. Numerical recipes in C: the art of scientific computing 1992, Cambridge University Press, pp. 412-9. 2nd ed.
92. The American College of Radiology (ACR), National Electrical Manufacturers Association (NEMA) Digital imaging and communications in medicine (DICOM) 1994, NEMA Standards Publications PS3-1993.
93. Pluim J.P.W., Maintz J.B.A., Viergever M.A. Mutual information matching in multiresolution contexts. Im Vis Comp 2001, 19:45-52.
94. Maes F., Vandermeulen D., Suetens P. Comparative evaluation of multiresolution optimization strategies for multimodality image registration by maximization of mutual information. Med Image Anal 1999, 3:373-386.
95. Burdett J., Stevens J., Flugel D., Williams E., Duncan J.S., Lemieux L. Increased sensitivity to pathological brain changes using co-registration of magnetic resonance imaging scans. Acta Radiol 2006, 47:1067-1072.
96. Erickson B.J., Mandrekar J., Wang L., Patriarche J.W., Bartholmai B.J., Wood C.P., et al. Effect of automated image registration on radiologist interpretation. J Digit Imaging 2007, 20:105-113.
97. Schröder W.J., Martin K.M., Lorensen W.E. The design and implementation of an object-oriented toolkit for 3D graphics and visualization. Proceedings of IEEE visualization '96, San Francisco, United States 1996, 93-100.
98. Van Leemput K., Hämäläinen J. A cross-platform software framework for medical image processing. Proceedings of medical image computing and computer-assisted intervention - MICCAI 2004, 1091-1092. SpringerLink, Saint-Malo, France.
99. Yoo T.S., Ackerman M.J., Lorensen W.E., Schroeder W., Chalana V., Aylward S., et al. Engineering and algorithm design for an image processing Api: a technical report on ITK-the Insight Toolkit. Stud Health Technol Inform 2002, 85:586-592.
100. Ibáñez L., Schroeder W. The ITK software guide 2.4 2005, Kitware, Inc.
101. Zamenhof R., Redmond E.2, Solares G., Katz D., Riley K., Kiger S., et al. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data. Int J Radiat Oncol Biol Phys 1996, 35:383-397.
102. Nigg D.W., Wemple C.A., Wessol D.E., Wheeler F.J. SERA - an advanced treatment planning system for neutron therapy and BNCT. Trans ANS 1999, 80:66-68.
103. Li H.S., Liu Y.W., Lee C.Y., Lin T.Y., Hsu F.Y. Verification of the accuracy of BNCT treatment planning system THORplan. Appl Radiat Isot 2009, 67:S122-S125.
104. Kotiluoto P., Hiisamäki P., Savolainen S. Application of the new MultiTrans SP3 radiation transport code in BNCT dose planning. Med Phys 2001, 28:1905-1910.
105. Briesemeister J.F. MCNP - a general Monte Carlo code N-particle transport code, Version 4C 2000, Computer program.
106. Rhoades W.A., Childs R.L. The DORT two-dimensional discrete ordinates transport code. Nucl Sci Eng 1988, 99:88-89.
107. Rhoades W.A., Simpson D.B. The TORT three-dimensional discrete ordinates neutron/photon transport code (TORT version 3), ORNL/TM-13221 1997, Computer program.
108. Ryynänen P.M., Kortesniemi M., Coderre J.A., Diaz A.Z., Hiismäki P., Savolainen S.E. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int J Radiat Oncol Biol Phys 2000, 48:1145-1154.
109. Koivunoro H., Auterinen I., Kosunen A., Kotiluoto P., Seppälä T., Savolainen S. Computational study of the required dimensions for standard sized phantoms in boron neutron capture therapy dosimetry. Phys Med Biol 2003, 48:N291-N300.
110. Kotiluoto P. Adaptive tree multigrids and simplified spherical harmonics approximation in deterministic neutral and charged particle transport. PhD thesis. VTT, Espoo; 2007.
111. Wojnecki C., Green S. A preliminary comparative study of two treatment planning systems developed for boron neutron capture therapy: MacNCTPlan and SERA. Med Phys 2002, 29:1710-1715.
112. Durisi E., Koivunoro H., Visca L., Borla O., Zanini A. Comparison of different MC techniques to evaluate BNCT dose profiles in phantom exposed tovarious neutron fields. Radiat Prot Dosim 2010, 138:213-222.
113. Koivunoro H., Kumada H., Seppälä T., Serén T., Kotiluoto P., Auterinen I., et al. Evaluation of SERA and JCDS dose determination methods and comparison to reaction rate measurements in phantom. Proceedings of 14th international congress on new challenges in neutron capture therapy, Buenos Aires, Argentina 2010, 250-252.
114. Kortesniemi M., Seppälä T., Auterinen I., Savolainen S. Enhanced blood boron concentration estimation for BPA-F mediated BNCT. Appl Radiat Isot 2004, 61:823-827.
115. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat Res 1999, 151:1-18.
116. Laakso J., Kulvik M., Ruokonen I., Vähätalo J., Zilliacus R., Färkkilä M., et al. Atomic emission method for total boron in blood during neutron-capture therapy. Clin Chem 2001, 47:1796-1803.
117. Linko S., Revitzer H., Zilliacus R., Kortesniemi M., Kouri M., Savolainen S. Boron detection from blood samples by ICP-AES and ICP-MS during boron neutron capture therapy. Scand J Clin Lab Invest 2008, 68:696-702.
118. Ryynänen P. Kinetic mathematical models for the 111In-labelled bleomycin complex and 10B in boron neutron capture therapy. PhD thesis. University of Helsinki, Helsinki; 2002.
119. 10B in blood after BPA-fructose complex infusion. Phys Med Biol 2002, 47:737-745.
120. Coderre J.A., Chanana A.D., Joel D.D., Elowitz E.H., Micca P.L., Nawrocky M.M., et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res 1998, 149:163-170.
121. Elowitz E.H., Bergland R.M., Coderre J.A., Joel D.D., Chadha M., Chanana A.D. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery 1998, 42:463-469.
122. Imahori Y., Ueda S., Ohmori Y., Kusuki T., Ono K., Fujii R., et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 1998, 39:325-333.
123. Imahori Y., Ueda S., Ohmori Y., Sakae K., Kusuki T., Kobayashi T., et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin Cancer Res 1998, 4:1825-1832.
124. Imahori Y., Ueda S., Ohmori Y., Sakae K., Kusuki T., Kobayashi T., et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res 1998, 4:1833-1841.
125. Aihara T., Hiratsuka J., Morita N., Uno M., Sakurai Y., Maruhashi A., et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck 2006, 28:850-855.
126. Nichols T.L., Kabalka G.W., Miller L.F., Khan M.K., Smith G.T. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med Phys 2002, 29:2351-2358.
127. Kabalka G.W., Tang C., Bendel P. The role of boron MRI in boron neutron capture therapy. J Neurooncol 1997, 33:153-161.
128. Bendel P., Zilberstein J., Salomon Y. In vivo detection of a boron-neutron-capture agent in melanoma by proton observed 1H-10B double resonance. Magn Reson Med 1994, 32:170-174.
129. Bendel P., Sauerwein W. Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): a comparison between 1H and 10B NMR. Med Phys 2001, 28:178-183.
130. Campanella R., Capuani S., Fasano F., Maraviglia B. Double resonance NMR imaging of BSH. Proceedings of research and development in neutron capture therapy, Bologna, Italy 2002, 963-965. Moduzzi Editore.
131. Porcari P., Capuani S., D'Amore E., Lecce M., La Bella A., Fasano F., et al. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). Phys Med Biol 2008, 53:6979-6989.
132. Porcari P., Capuani S., D'Amore E., Lecce M., La Bella A., Fasano F., et al. In vivo 19F MR imaging and spectroscopy for the BNCT optimization. Appl Radiat Isot 2009, 67:S365-S368.
133. Zuo C.S., Prasad P.V., Busse P., Tang L., Zamenhof R.G. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy. Med Phys 1999, 26:1230-1236.
134. Bendel P., Margalit R., Koudinova N., Salomon Y. Noninvasive quantitative in vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging. Radiat Res 2005, 164:680-687.
135. Bendel P., Margalit R., Salomon Y. Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine. Magn Reson Med 2005, 53:1166-1171.
136. Timonen M. Proton magnetic resonance spectroscopy of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex. PhD thesis. University of Helsinki, Helsinki; 2010.
137. Yamamoto Y., Isobe T., Yamamoto T., Shibata Y., Anno I., Nakai K., et al. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy. Appl Radiat Isot 2009, 67:S345-S347.
138. Timonen M., Kankaanranta L., Lundbom N., Collan J., Kangasmäki A., Kortesniemi M., et al. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose. Eur J Radiol 2005, 56:154-159.
139. Timonen M., Kankaanranta L., Lundbom N., Kortesniemi M., Seppälä T., Kouri M., et al. Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study. J Radiat Res 2009, 50:435-440.
140. Munck af Rosenschold P.M., Verbakel W.F., Ceberg C.P., Stecher-Rasmussen F., Persson B.R. Toward clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy. Med Phys 2001, 28:787-795.
141. Verbakel W.F., Sauerwein W., Hideghety K., Stecher-Rasmussen F. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope. Int J Radiat Oncol Biol Phys 2003, 55:743-756.
142. Verbakel W.F. Validation of the scanning-gamma-ray telescope for in vivo dosimetry and boron measurements during BNCT. Phys Med Biol 2001, 46:3269-3285.
143. Wittig A., Malago M., Collette L., Huiskamp R., Buhrmann S., Nievaart V., et al. Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). Int J Cancer 2008, 122:1164-1171.
144. Auterinen I., Anttila K., Kotiluoto P., Serén T., Savolainen S., Kosunen A., et al. Experiments and simulations for prompt-gamma imaging of boron and hydrogen neutron capture reactions in boron neutron capture therapy. Proceedings of the XXXVII annual conference of the Finnish physical society, Helsinki, Finland 2003.
145. Kobayashi T., Sakurai Y., Ishikawa M. A noninvasive dose estimation system for clinical BNCT based on PG-SPECT-conceptual study and fundamental experiments using HPGe and CdTe semiconductor detectors. Med Phys 2000, 27:2124-2132.
146. Ishikawa M., Kobayashi T., Sakurai Y., Kanda K. Optimization technique for a prompt gamma-ray SPECT collimator system. J Radiat Res 2001, 42:387-400.
147. Munck af Rosenschöld P., Minarik D., östlund C., Ljungberg M., Ceberg C. Prompt gamma tomography during BNCT - a feasibility study. J Inst 2006, 1:P05003.
148. Valda A.A., Minsky D.M., Kreiner A.J., Burlon A.A., Somacal H. Development of a tomographic system for online dose measurements in BNCT (Boron neutron capture therapy). Braz J Phys 2005, 35.
149. Minsky D.M., Valda A.A., Kreiner A.J., Green S., Wojnecki C., Ghani Z. First tomographic image of neutron capture rate in a BNCT facility. Appl Radiat Isot 2011, 69:1858-1861.
150. van Westen D., Latt J., Englund E., Brockstedt S., Larsson E.M. Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy. Acta Radiol 2006, 47:311-319.
151. Kuusela L., Sipilä O., Lundbom N., Kankaanranta L., Savolainen S. Diffusion tensor imaging using rigid co-registration in assessing the effect of boron neutron capture therapy on brain tissue. Int J CARS 2009, 4:311-355.
152. Mardor Y., Pfeffer R., Spiegelmann R., Roth Y., Maier S.E., Nissim O., et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003, 21:1094-1100.
153. Kim S., Loevner L., Quon H., Sherman E., Weinstein G., Kilger A., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009, 15:986-994.
154. Bennett K.M., Hyde J.S., Rand S.D., Bennett R., Krouwer H.G., Rebro K.J., et al. Intravoxel distribution of DWI decay rates reveals C6 glioma invasion in rat brain. Magn Reson Med 2004, 52:994-1004.
155. Kwee T.C., Galban C.J., Tsien C., Junck L., Sundgren P.C., Ivancevic M.K., et al. Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas. NMR Biomed 2010, 23:179-187.
156. Moffat B.A., Hall D.E., Stojanovska J., McConville P.J., Moody J.B., Chenevert T.L., et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004, 17:249-259.
157. Moffat B.A., Chenevert T.L., Lawrence T.S., Meyer C.R., Johnson T.D., Dong Q., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005, 102:5524-5529.
158. Hamstra D.A., Rehemtulla A., Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007, 25:4104-4109.
159. Hamstra D.A., Galban C.J., Meyer C.R., Johnson T.D., Sundgren P.C., Tsien C., et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 2008, 26:3387-3394.
160. Galban C.J., Mukherji S.K., Chenevert T.L., Meyer C.R., Hamstra D.A., Bland P.H., et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009, 2:184-190.
161. Young R.J., Knopp E.A. Brain MRI: tumor evaluation. J Magn Reson Imaging 2006, 24:709-724.
162. Kashimura H., Inoue T., Beppu T., Ogasawara K., Ogawa A. Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy-three case reports. Clin Neurol Neurosurg 2007, 109:106-110.
163. Lope-Piedrafita S., Garcia-Martin M.L., Galons J.P., Gillies R.J., Trouard T.P. Longitudinal diffusion tensor imaging in a rat brain glioma model. NMR Biomed 2008, 21:799-808.
164. Zhang J., van Zijl P.C., Laterra J., Salhotra A., Lal B., Mori S., et al. Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI. Magn Reson Med 2007, 58:454-462.
165. Thwaites D.I., Burns D.T., Klevenhagen S.C., Nahum A.E., Pitchford W.G. The IPEMB code of practice for electron dosimetry for radiotherapy beams of initial energy from 2 to 50 MeV based on air kerma calibration. Phys Med Biol 1996, 41:2557-2603.
166. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984, 23:379-391.
167. Radiation therapy planning 1983, Marcel Dekker. N. Bleehen, E. Glatstein, J. Haybittle (Eds.).
168. Kosunen A. Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams. PhD thesis. University of Helsinki; 1999.
169. Yamamoto T., Nakai K., Nariai T., Kumada H., Okumura T., Mizumoto M., et al. The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation. Appl Radiat Isot 2011, 69:1817-1818.
170. Nigg D.W. Current trends and progress in the physics of BNCT. Frontiers in neutron capture therapy 2001, 13-21. Kluwer Academic/Plenum Publishing Corporation. M.F. Hawthorne, K. Shelly, R.J. Wiersema (Eds.).
171. Geninatti-Crich S., Alberti D., Szabo I., Deagostino A., Toppino A., Barge A., et al. MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters. Chemistry 2011, 17:8479-8486.
172. Kimura S., Masunaga S., Harada T., Kawamura Y., Ueda S., Okuda K., et al. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy. Bioorg Med Chem 2011, 19:1721-1728.
173. Cappelli A., Valenti S., Mancini A., Giuliani G., Anzini M., Altieri S., et al. Carborane-conjugated 2-quinolinecarboxamide ligands of the translocator protein for boron neutron capture therapy. Bioconjug Chem 2010, 21:2213-2221.